Iris van Dam
Impact in
- Radiation top 5%
- Advanced Radiotherapy Techniques
-
- Lung Cancer Research Studies
- Cancer survivorship and care
- COVID-19 and healthcare impacts
Papers in
- Oncology 7
- COVID-19 and healthcare impacts 4
- Cancer survivorship and care 4
- Lung Cancer Research Studies 2
-
- Advanced Radiotherapy Techniques 4
- Co-authors
- Ben J. Slotman (4 shared papers)Suresh Senan (3 shared papers)Helena Marieke Verkooijen (10 shared papers)Dennis R. Schaart (1 shared paper)Thijs van Dalen (7 shared papers)Abrahim Al‐Mamgani (1 shared paper)Rebecca Muirhead (1 shared paper)Steven van de Water (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (3 papers)Radiotherapy and Oncology (2 papers)European Journal of Cancer (2 papers)Breast Cancer Research and Treatment (2 papers)Quality of Life Research (1 paper)
- Partner nations
- NetherlandsUnited Kingdom
In The Last Decade
Iris van Dam
17 papers receiving 441 citations
Peers
Comparison fields: 5 of 34
- Radiation 144
- Oncology 139
- Cancer Research 60
- Pulmonary and Respiratory Medicine 63
- Radiology, Nuclear Medicine and Imaging 44
Countries citing papers authored by Iris van Dam
This map shows the geographic impact of Iris van Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris van Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris van Dam more than expected).
Fields of papers citing papers by Iris van Dam
This network shows the impact of papers produced by Iris van Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris van Dam. The network helps show where Iris van Dam may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris van Dam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 77 | |
| 2 | 2020 | 63 | |
| 3 | 2016 | 60 | |
| 4 | 2010 | 58 | |
| 5 | 2014 | 57 | |
| 6 | 2019 | 53 | |
| 7 | 2020 | 27 | |
| 8 | 2015 | 14 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 10 | |
| 11 | 2024 | 7 | |
| 12 | 2024 | 4 | |
| 13 | 2016 | 3 | |
| 14 | [Severe anaemia caused by Human Parvovirus B19 infection in a patient with autoimmune haemolytic anaemia and a B-cell non-Hodgkin lymphoma]. | 2008 | 2 |
| 15 | 2023 | 2 | |
| 16 | 2023 | 1 | |
| 17 | 2024 | 1 |
About Iris van Dam
Iris van Dam is a scholar working on Oncology, Radiation, Cancer Research, Surgery and Infectious Diseases, having authored 17 papers that have together received 452 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (4 papers), Cancer survivorship and care (4 papers), Advanced Radiotherapy Techniques (4 papers), Breast Cancer Treatment Studies (3 papers), Breast Implant and Reconstruction (2 papers), Lung Cancer Research Studies (2 papers), Parvovirus B19 Infection Studies (1 paper) and Radiation Therapy and Dosimetry (1 paper). The work is most often cited by research in Radiation (144 citations), Oncology (139 citations), Cancer Research (60 citations), Pulmonary and Respiratory Medicine (63 citations) and Radiology, Nuclear Medicine and Imaging (44 citations). Iris van Dam has collaborated with scholars based in Netherlands and United Kingdom. Frequent co-authors include Ben J. Slotman, Suresh Senan, Helena Marieke Verkooijen, Dennis R. Schaart, Thijs van Dalen, Abrahim Al‐Mamgani, Rebecca Muirhead, Steven van de Water, Ben Heijmen and Gerard G. Hanna. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology, European Journal of Cancer, Breast Cancer Research and Treatment and Quality of Life Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.